Dexcom (DXCM) Cash & Equivalents Growth (3y) (2013 - 2026)
Powered by 
Analysis
Dexcom (DXCM) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn | -13.31% |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | -7.03% |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn | 8.09% |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn | 34.27% |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn | 8.16% |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn | 40.74% |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn | 27.03% |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn | -2.57% |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn | 32.23% |
| 10 | Zimmer Biomet Holdings | 18.11 Bn | 17.70 Bn | 1.54 Bn | 8.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.57% |
| Mar 31, 2026 | 21.52% |
| Dec 31, 2025 | 12.63% |
| Sep 30, 2025 | 38.03% |
| Jun 30, 2025 | 16.37% |
| Mar 31, 2025 | 8.12% |
| Dec 31, 2024 | -16.81% |
| Sep 30, 2024 | -24.52% |
| Jun 30, 2024 | -6.76% |
| Mar 31, 2024 | 5.07% |
| Dec 31, 2023 | -11.52% |
| Sep 30, 2023 | -1.50% |
| Jun 30, 2023 | 31.12% |
| Mar 31, 2023 | 2.15% |
| Dec 31, 2022 | 12.91% |
| Sep 30, 2022 | 20.84% |
| Jun 30, 2022 | 1.22% |
| Mar 31, 2022 | -17.71% |
| Dec 31, 2021 | -2.54% |
| Sep 30, 2021 | 57.82% |